These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 32811334)

  • 1. Protein transduction domain-mediated influenza NP subunit vaccine generates a potent immune response and protection against influenza virus in mice.
    Yin Y; Li B; Zhou L; Luo J; Liu X; Wang S; Lu Q; Tan W; Chen Z
    Emerg Microbes Infect; 2020 Dec; 9(1):1933-1942. PubMed ID: 32811334
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of cross-protection against influenza A virus by DNA prime-intranasal protein boost strategy based on nucleoprotein.
    Luo J; Zheng D; Zhang W; Fang F; Wang H; Sun Y; Ding Y; Xu C; Chen Q; Zhang H; Huang D; Sun B; Chen Z
    Virol J; 2012 Nov; 9():286. PubMed ID: 23173785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influenza A virus nucleoprotein derived from Escherichia coli or recombinant vaccinia (Tiantan) virus elicits robust cross-protection in mice.
    Huang B; Wang W; Li R; Wang X; Jiang T; Qi X; Gao Y; Tan W; Ruan L
    Virol J; 2012 Dec; 9():322. PubMed ID: 23272943
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cross-protection against influenza virus infection by intranasal administration of nucleoprotein-based vaccine with compound 48/80 adjuvant.
    Zheng M; Liu F; Shen Y; Wang S; Xu W; Fang F; Sun B; Xie Z; Chen Z
    Hum Vaccin Immunother; 2015; 11(2):397-406. PubMed ID: 25607884
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Broadly protective immunity against divergent influenza viruses by oral co-administration of Lactococcus lactis expressing nucleoprotein adjuvanted with cholera toxin B subunit in mice.
    Lei H; Peng X; Jiao H; Zhao D; Ouyang J
    Microb Cell Fact; 2015 Aug; 14():111. PubMed ID: 26242406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An approach to the influenza chimeric subunit vaccine (3M2e-HA2-NP) provides efficient protection against lethal virus challenge.
    Saleh M; Nowroozi J; Farahmand B; Fotouhi F
    Biotechnol Lett; 2020 Jul; 42(7):1147-1159. PubMed ID: 32152828
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influenza Chimeric Protein (3M2e-3HA2-NP) Adjuvanted with PGA/Alum Confers Cross-Protection against Heterologous Influenza A Viruses.
    Kwak C; Nguyen QT; Kim J; Kim TH; Poo H
    J Microbiol Biotechnol; 2021 Feb; 31(2):304-316. PubMed ID: 33263336
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cross-protection against influenza virus infection by intranasal administration of M1-based vaccine with chitosan as an adjuvant.
    Sui Z; Chen Q; Fang F; Zheng M; Chen Z
    Vaccine; 2010 Nov; 28(48):7690-8. PubMed ID: 20870054
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microneedle delivery of an M2e-TLR5 ligand fusion protein to skin confers broadly cross-protective influenza immunity.
    Wang BZ; Gill HS; He C; Ou C; Wang L; Wang YC; Feng H; Zhang H; Prausnitz MR; Compans RW
    J Control Release; 2014 Mar; 178():1-7. PubMed ID: 24417966
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protection against homo and hetero-subtypic influenza A virus by optimized M2e DNA vaccine.
    Yao Y; Wang H; Chen J; Shao Z; He B; Chen J; Lan J; Chen Q; Chen Z
    Emerg Microbes Infect; 2019; 8(1):45-54. PubMed ID: 30866759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Robust immunity and heterologous protection against influenza in mice elicited by a novel recombinant NP-M2e fusion protein expressed in E. coli.
    Wang W; Huang B; Jiang T; Wang X; Qi X; Gao Y; Tan W; Ruan L
    PLoS One; 2012; 7(12):e52488. PubMed ID: 23285063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. M2SR, a novel live influenza vaccine, protects mice and ferrets against highly pathogenic avian influenza.
    Hatta Y; Boltz D; Sarawar S; Kawaoka Y; Neumann G; Bilsel P
    Vaccine; 2017 Jul; 35(33):4177-4183. PubMed ID: 28668565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of antinucleoprotein IgG by systemic vaccination and its effect on influenza virus clearance.
    Lamere MW; Moquin A; Lee FE; Misra RS; Blair PJ; Haynes L; Randall TD; Lund FE; Kaminski DA
    J Virol; 2011 May; 85(10):5027-35. PubMed ID: 21367900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single mucosal vaccination targeting nucleoprotein provides broad protection against two lineages of influenza B virus.
    Kim MH; Kang JO; Kim JY; Jung HE; Lee HK; Chang J
    Antiviral Res; 2019 Mar; 163():19-28. PubMed ID: 30639307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting the HA2 subunit of influenza A virus hemagglutinin via CD40L provides universal protection against diverse subtypes.
    Fan X; Hashem AM; Chen Z; Li C; Doyle T; Zhang Y; Yi Y; Farnsworth A; Xu K; Li Z; He R; Li X; Wang J
    Mucosal Immunol; 2015 Jan; 8(1):211-20. PubMed ID: 25052763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inactivated Influenza Vaccine That Provides Rapid, Innate-Immune-System-Mediated Protection and Subsequent Long-Term Adaptive Immunity.
    Chua BY; Wong CY; Mifsud EJ; Edenborough KM; Sekiya T; Tan AC; Mercuri F; Rockman S; Chen W; Turner SJ; Doherty PC; Kelso A; Brown LE; Jackson DC
    mBio; 2015 Oct; 6(6):e01024-15. PubMed ID: 26507227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protective cellular and mucosal immune responses following nasal administration of a whole gamma-irradiated influenza A (subtype H1N1) vaccine adjuvanted with interleukin-28B in a mouse model.
    Sabbaghi A; Zargar M; Zolfaghari MR; Motamedi-Sedeh F; Ghaemi A
    Arch Virol; 2021 Feb; 166(2):545-557. PubMed ID: 33409549
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improving Cross-Protection against Influenza Virus Using Recombinant Vaccinia Vaccine Expressing NP and M2 Ectodomain Tandem Repeats.
    Wang W; Huang B; Wang X; Tan W; Ruan L
    Virol Sin; 2019 Oct; 34(5):583-591. PubMed ID: 31240620
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intranodal administration of mRNA encoding nucleoprotein provides cross-strain immunity against influenza in mice.
    Joe PT; Christopoulou I; van Hoecke L; Schepens B; Ysenbaert T; Heirman C; Thielemans K; Saelens X; Aerts JL
    J Transl Med; 2019 Jul; 17(1):242. PubMed ID: 31345237
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cross-protection against influenza virus infection by intranasal administration of M2-based vaccine with chitosan as an adjuvant.
    Sui Z; Chen Q; Wu R; Zhang H; Zheng M; Wang H; Chen Z
    Arch Virol; 2010 Apr; 155(4):535-44. PubMed ID: 20195654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.